Rational Design of Anti-diabetic Agents
<p> The Glucagon-like peptide 1 receptor (GLP-1R) belongs to the pharmaceutically important Class B family of G-protein coupled receptors (GPCRs) and its incretin peptide ligand GLP-1 analogs are adopted drugs for the treatment of type 2 diabetes (T2D). Despite remarkable anti-diabetic effects...
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
University of the Sciences in Philadelphia
2019
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=13861629 |